SAO PAULO (Reuters) – The General Superintendence of the Administrative Council for Economic Defense (Cade) recommended the approval, without restrictions, of the sale of part of Sanofi’s assets in Latin America by Hypera, according to an order in the Official Gazette on Monday. fair.
In December, the superintendent had declared the deal “complex” and requested more information from the parties, given the potential high concentrations in categories such as laxatives, stimulants and prescription nasal decongestants.
The transaction, announced in July 2021, involves the acquisition of over-the-counter and prescription drug brands in Brazil, Mexico and Colombia for US$190.3 million. Among the products are the analgesic AAS, the herbal medicine Naturetti and the antiseptic Cepacol.
In November, Hypera announced the sale to the Eurofarma laboratory of a portfolio of pharmaceutical products in Colombia and Mexico for US$51.6 million.
(By Andre Romani)
The post Cade Superintendence recommends approval of sale of Sanofi assets to Hypera appeared first on ISTOÉ DINHEIRO.
#Cade #Superintendence #recommends #approval #sale #Sanofi #assets #Hypera #ISTOÉ #DINHEIRO